Related Experiment Video
Updated: May 9, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
PM2.5 constituents and hospitalizations of full-spectrum cardiovascular diseases: A national case-crossover study
Dawei Lv1, Ziwei Peng1, Yixuan Jiang1
1Shanghai Institute of Infectious Disease and Biosecurity, School of Public Health, Fudan University, Shanghai, 200032, China.
Abstract:
Multicenter evidence remains limited regarding the short-term impacts of fine particulate matter (PM2.5) constituents on specific cardiovascular disease (CVD) outcomes. This study assessed the short-term links between PM2.5 chemical constituents and CVD hospitalizations in China. Hospitalization data for 10 broad categories and 40 cause-specific CVD outcomes were collected from 153 hospitals across 20 provinces in China during 2013-2020. A time-stratified case-crossover design was applied. Five major constituents of PM2.5, namely black carbon, organic matter (OM), sulfate (SO42-), nitrate (NO3-), and ammonium, were extracted from the Tracking Air Pollution datasets. PM2.5 and its constituents were associated with higher hospitalization risk for six CVD categories: hypertensive diseases, ischemic heart diseases, pulmonary heart diseases, cerebrovascular diseases, diseases of veins, lymphatic vessels and lymph nodes, and other forms of heart disease. The largest effect estimates were observed on lag 0-1 day, ranging from 0.72% to 4.87% per interquartile range increase in PM2.5 and its constituents. Significant associations were also observed for 15 specific causes of CVDs. OM, SO42-, and NO3- generally showed larger effect estimates than the other constituents. The concentration-response curves exhibited mostly positive trends. Associations were stronger among males and elderly people, and during the cold season. This nationwide study offers insights into the effects of PM2.5 constituents on CVD hospitalizations, highlighting the necessity for targeted control of these PM2.5 constituents.
Related Concept Videos
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease IV: Preventive Measures